天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

返回ChemicalBook首頁(yè)>CAS數(shù)據(jù)庫(kù)列表>90614-48-5

90614-48-5

中文名稱 抑二肽素A
英文名稱 DIPROTIN A
CAS 90614-48-5
分子式 C17H31N3O4
MDL 編號(hào) MFCD00038707
分子量 341.45
MOL 文件 90614-48-5.mol
更新日期 2024/12/18 11:18:05
90614-48-5 結(jié)構(gòu)式 90614-48-5 結(jié)構(gòu)式

基本信息

中文別名
脯氨抑素
抑二肽素A
三肽抑制劑IPI
L-異亮氨酰-L-脯氨酰-L-異亮氨酸
抑二肽素A ≥97%(-20℃) (HPLC)
英文別名
DIPROTIN A
所屬類別
生物化工:多肽

物理化學(xué)性質(zhì)

沸點(diǎn)583.1±50.0 °C(Predicted)
密度1.140±0.06 g/cm3(Predicted)
儲(chǔ)存條件−20°C
儲(chǔ)存條件-20°C
溶解度DMSO:250.0(Max Conc. mg/mL);732.17(Max Conc. mM)
Water:67.08(Max Conc. mg/mL);196.44(Max Conc. mM)
酸度系數(shù)(pKa)3.72±0.22(Predicted)
形態(tài)白色至類白色固體
顏色White to off-white
水溶解性Soluble in water at 1mg/ml
CAS 數(shù)據(jù)庫(kù)90614-48-5(CAS DataBase Reference)

安全數(shù)據(jù)

WGK Germany3
WGK Germany3
RTECS號(hào)NR4737000

知名試劑公司產(chǎn)品信息

常見問題列表

生物活性
Diprotin A (Ile-Pro-Ile) 是二肽基肽酶 IV (DPP-IV) 的抑制劑。
靶點(diǎn)

IC50: DPP-IV

體外研究

Diprotin A (100?μM; 30?minutes after CXCR4-blocker or Src-inhibitor treatment) induces the phosphorylation of Src [Tyr 416] and VE-cadherin [Tyr731] in hECs in both normoxia and H/R conditions in human endothelial cells and disrupts endothelial cell-to-cell junctions, which are attenuated by CXCR4 (receptor of SDF-1α)-blocker or Src-inhibitor.

Western Blot Analysis

Cell Line: Human endothelial cells [1]
Concentration: 100?μM
Incubation Time: 30?minutes after CXCR4-blocker or Src-inhibitor treatment
Result: Induced the phosphorylation of Src [Tyr 416] and VE-cadherin [Tyr731] in hECs.
體內(nèi)研究

Diprotin A (intraperitoneal injection; 70?μg/kg; twice daily; 7 days) increases the phosphorylation of Src and VE-cadherin and aggravates vascular leakage in the retinas. Collectively, Diprotin A induces vascular leakage by augmenting the SDF-1α/CXCR4/Src/VE-cadherin signaling pathway.

Animal Model: Streptozotocin-induced diabetic retinopathy model in wild-type C57/BL6 mice
Dosage: 70?μg/kg
Administration: Intraperitoneal injection; twice daily; 7 days
Result: Induced vascular leakage by augmenting the SDF-1α/CXCR4/Src/VE-cadherin signaling pathway.
"90614-48-5" 相關(guān)產(chǎn)品信息
90614-48-5 767-10-2 443-79-8 7154-73-6 26116-12-1